We have deep experience on both the buy and sell-side, and work with our clients to ensure that partnership, licensing and investment decisions are taken with confidence, along with clear alignment between transaction price and asset value.
Scroll down to learn more
Alacrita's technical and scientific expertise allows it to deeply understand the science behind biotech and pharmaceutical assets - a core advantage in all business development work we do. Whether it’s in the ability to recognize potential assets when scouting, in developing the right assumptions for a valuation model, or with delivering due diligence that provides a complete and accurate assessment, knowing the science makes us more effective.
Our consultants typically average 20-30 years of industry experience and bring significant first-hand knowledge to every project. Our core team works hand in hand with our Expert Network, which contains over 75 expert business development consultants, and more than 250 high-caliber consultants in total. Having this substantial resource at our fingertips allows us to provide precisely relevant expertise tailored to the specifics of each project, across a full range of product modalities and disease areas.
Contact us today to learn how our pharma & biotech consulting expertise can serve your project.
Contact us© 2023 Alacrita Holdings Limited | Pharma & Biotech Consulting
Alacrita Consulting
2 Royal College St
London, UK
NW1 0NH
Registered in England & Wales.
No. 10530608
One Broadway
Floor 14
Cambridge, MA 02142
Registered in Massachusetts.
